Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients

被引:1
作者
Kurosumi, M
Tabei, T
Inoue, K
Takei, H
Ninomiya, J
Naganuma, R
Suemasu, K
Higashi, Y
Tsuchiya, E
机构
[1] Saitama Canc Ctr, Dept Pathol, Ina, Saitama 3620806, Japan
[2] Saitama Canc Ctr, Dept Endocrine Internal Med, Ina, Saitama 3620806, Japan
[3] Saitama Canc Ctr, Dept Breast Surg, Ina, Saitama 3620806, Japan
[4] Saitama Canc Ctr, Inst Res, Ina, Saitama 3620806, Japan
关键词
breast cancer; node-negative; invasive ductal carcinoma; prognostic factor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study aimed to determine the prognostic significance of histological scoring system based on heterogeneity of invasive ductal carcinoma, for node-negative breast cancer patients. We studied 108 patients of node-negative invasive ductal carcinoma with invasive tumor >5 mm. Histological score of each patient was evaluated based on histological subtype of invasive ductal carcinoma and pattern of. its heterogeneity. Score of each subtype was defined as follows; papillotubular carcinoma: score 1, solid-tubular carcinoma: score 2 and scirrhous carcinoma: score 3. The existence of histological heterogeneity was examined, and corresponding score was doubled in a pure case and scores of two dominant subtypes were summed in a composite case. Overall survival curves defined by sores were drawn by Kaplan-Meier method and the difference in survival rate was evaluated by log-rank test. The most significant difference of overall survival was recognized between low score group (scores 2, 3 and 4) and high score group (scores 5 and 6) (p < 0.001). In addition, multivariate analysis confirmed that only histological score was an independent prognostic factor. These results suggested that assessment of histological heterogeneity of invasive ductal carcinoma could serve as independent potent prognostic factor for node-negative invasive ductal carcinoma of the breast, and this method might be useful to decide indication of postoperative adjuvant chemotherapy.
引用
收藏
页码:833 / 837
页数:5
相关论文
共 16 条
[1]  
*AM CANC SOC, 1993, CANCER, V74, P221
[2]   The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer [J].
Clahsen, PC ;
van de Velde, CJH ;
Duval, C ;
Pallud, C ;
Mandard, AM ;
Delobelle-Deroide, A ;
van den Broek, L ;
van de Vijver, MJ .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1999, 25 (04) :356-363
[3]  
DEXTER DL, 1978, CANCER RES, V38, P3174
[4]  
FISHMAN E, 1993, J CLIN EXP NEUROPSYC, V15, P71
[5]   EVALUATING THE POTENTIAL USEFULNESS OF NEW PROGNOSTIC AND PREDICTIVE INDICATORS IN NODE-NEGATIVE BREAST-CANCER PATIENTS [J].
GASPARINI, G ;
POZZA, F ;
HARRIS, AL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (15) :1206-1219
[6]  
GLEASON DF, 1974, J UROLOGY, V111, P56
[7]   Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer [J].
Goldhirsch, A ;
Glick, JH ;
Gelber, RD ;
Senn, HJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (21) :1601-1608
[8]   Meeting highlights: International consensus panel on the treatment of primary breast cancer [J].
Goldhirsch, A ;
Glick, JH ;
Gelber, RD ;
Coates, AS ;
Senn, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3817-3827
[9]  
*JAP BREAST CANC S, 1998, GEN RUL CLIN PATH RE, P28
[10]   Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer [J].
Kato, T ;
Kimura, T ;
Miyakawa, R ;
Fujii, A ;
Yamamoto, K ;
Kameoka, S ;
Nishikawa, T ;
Kasajima, T .
BRITISH JOURNAL OF CANCER, 2000, 82 (02) :404-411